Results 221 to 230 of about 280,160 (254)

Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology.

ACS Applied Materials and Interfaces
Apolipoprotein A1 (Apo-A1) is a well-recognized biomarker in tissues, closely associated with cardiovascular diseases such as atherosclerosis, coronary artery disease, and heart failure.
Baihe Sun, Guanghui Li, Yue Wu, J. Gai, Min Zhu, Weiwei Ji, Xiaoying. Wang, Fenghua Zhang, Wanting Li, Jin Hu, Yuxin Lou, G. Feng, Xijun Han, Jin-Xing Dong, Jiayuan Peng, Jiawei Pei, Y. Wan, Yanfei Li, Linlin Ma   +18 more
semanticscholar   +1 more source

Low diurnal variability of apolipoprotein A1, apolipoprotein B and apolipoprotein B/apolipoprotein A1 ratio during normal sleep and after an acute shift of sleep

Clinical Biochemistry, 2008
The aim of this study was to study the diurnal variation of the cardiovascular risk markers apolipoprotein A1 and B and apo B/apo A1 ratio.We have studied the diurnal variation of apolipoprotein A1, apolipoprotein B and apo B/apo A1 ratio during night sleep and the day sleep conditions in seven healthy volunteers (age 22-32 yr).
Anders, Larsson, Lena, Carlsson, John, Axelsson   +2 more
openaire   +2 more sources

A simple electrochemical immunosensor platform for detection of Apolipoprotein A1 (Apo-A1) as a bladder cancer biomarker in urine

Sensors and Actuators B: Chemical, 2019
Bladder cancer is one of the tumors associated with the highest mortality rate. It is clinically characterized by high recurrent rates and poor prognosis once tumors invade the lamina propia. Nevertheless, current diagnostic techniques such as cystoscopy
Seongchan Kim, Young Joo Kim, Sunga Song, Kook-Nyung Lee, Wookyeong Seong   +4 more
semanticscholar   +1 more source

Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis

European Journal of Gastroenterology & Hepatology, 2015
Nonalcoholic steatohepatitis (NASH) is a prevalent liver disease that is increasingly being associated with cardiovascular disease. Ursodeoxycholic acid (UDCA) may have antioxidant and anti-inflammatory activities, and may reduce liver injury in NASH. To date, no studies have assessed the efficacy of UDCA in carotid intima media thickness (CIMT), serum
COSKUN, Banu D. Ozel, YURCI, Alper, Yucesoy, Mehmet, BAŞKOL, Mevlüt, DOĞAN, Serap, Yagbasan, Ahmet, GÜRSOY, Şebnem, BAŞKOL, Gülden   +7 more
openaire   +3 more sources

Associations Between Apolipoprotein A1, High-Density Lipoprotein Cholesterol, and Urinary Cytokine Levels in Elderly Males and Females

Journal of Interferon and Cytokine Research, 2020
There exists a close relationship between cardiovascular diseases and chronic kidney disease. Apolipoprotein A1 and high-density lipoprotein (HDL) cholesterol are widely used as cardiovascular risk markers but they also have anti-inflammatory properties.
B. Fellström, J. Helmersson-Karlqvist, L. Lind, I. Soveri, Ping-Hsun Wu, Måns Thulin, J. Ärnlöv, A. Larsson   +7 more
semanticscholar   +1 more source

Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.

Diabetes Research and Clinical Practice, 2018
AIMS Lipid parameters, lipid risk indexes and lipid-related oxidative stress markers (paraoxonase 1 [PON1] and lipid peroxides [LPO]) reflect the actual status of lipid metabolism in type 2 diabetes (T2DM).
A. Viktorinova, I. Jurkovičová, Ľ. Fábryová, S. Kinova, M. Koren, A. Stecova, K. Sviteková   +6 more
semanticscholar   +1 more source

Genetic relationship between equine apolipoproteins A4 and A1

Animal Genetics, 1997
Genetic polymorphism of equine apolipoprotein (APO) A4 was investigated using two‐dimensional electrophoresis in four horse breeds, including Japanese native horses. A linkage relationship between the equine APOA4 and APOA1 structural loci was assumed from the segregation data of these loci in one family line of the Japanese Hokkaido native breed.
H, Kakoi, H, Gawahara
openaire   +2 more sources

[Apolipoprotein A1 and apolipoprotein B in pleural effusions].

Revista clinica espanola, 2005
To determine the levels of apolipoprotein A1 and apolipoprotein B in pleural effusions and analyze their possible diagnostic value.A total of 117 patients with pleural effusion (30 transudates and 87 exudates) were included. The apolipoproteins were measured by turbidimetry.The apolipoprotein B values in serum were slightly lower in transudates than in
E, García Pachón, I L, Llorca Escuin
openaire   +1 more source

Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.

Clinical Biochemistry, 2018
OBJECTIVE Advanced glycation end products (AGEs) are involved in the pathogenesis of Alzheimer's disease (AD). Specific AGEs and related autoantibodies may be early AD markers. Apolipoprotein A1 (ApoA1) and its post-translational modifications (PTMs) are
Ching-Yu Lin, J. Sheu, I-Shih Tsai, Sen-Te Wang, Li-Yu Yang, I-Uen Hsu, Hui-Wen Chang, Horng-mo Lee, S. Kao, Ching-Kuo Lee, Chien‐Ho Chen, Yung-Feng Lin   +11 more
semanticscholar   +1 more source

Observed relationship between ratios HDL-cholesterol/total cholesterol and apolipoprotein A1/apolipoprotein B

Clinical Biochemistry, 1992
Epidemiological evidence suggests that the ratio HDL-cholesterol (HDL-C)/total cholesterol (TC) or apolipoprotein A1 (apo A1)/apolipoprotein B (apo B) are good indicators of coronary heart disease risk. In investigating the distribution of these ratios in the typical population served by our routine laboratory, we analysed the lipid results of 541 ...
J M, Kuyl, D, Mendelsohn
openaire   +2 more sources